Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: A prospective randomized study

Journal of Clinical Oncology

Volumn 19, Issue 11, 2001, Pages 2788-2796

  Berglund, G ^a   Nystedt, M ^a   Bolund, C ^a   Sjoden P O ^a   Rutquist, L E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; GOSERELIN; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY;

EID: 0035367929     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.11.2788     Document Type: Article

References (23)

1. Steroid hormones, the menopause, sexuality and well-being of women
2. Reproductive health, use of estrogen and experience of symptoms in premenopausal women: A population-based study
3. Sexuality in women receiving chemotherapy for breast cancer
4. Breast cancer survivors (BCS): Sexuality and intimacy concerns
5. Sexual functioning after breast cancer: A conceptional framework for future studies
6. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning
7. The impact of breast cancer on sexuality, body image, and intimate relationships
8. A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer
9. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: Report of a workshop
10. Zoladex and tamoxifen as adjuvant therapy in premenopausal breast cancer: A randomised trial by the Cancer Research Campaign (C.R.C.) Breast Cancer Thais Group, the Stockholm Breast Cancer Study Group, the South-East Sweden Breast Cancer Group & the Gruppo Interdisciplinaire Valutazione Interventi in Oncologia (G.I.V.I.O.)
11. Effects of chemohormonal therapy in premenopausal node (+), receptor (+) breast cancer: An Eastern Cooperative Oncology Group phase III Intergroup Trial (E5188 INT-0101)
12. Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: Four-year results of the Austrian Breast Cancer Study Group (ABCSG) Trial 5
13. Partial mastectomy and breast reconstruction: A comparison of their effects on psychosocial adjustment, body image and sexuality
14. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors
15. The sexual side effects of current treatments for breast cancer
16. The role of androgen in the maintenance of sexual functioning in oophorectomized women
17. The psychoendocrinology
18. Effects of tamoxifen on the female genital tract
19. Adjuvant endocrine therapy in premenopausal breast cancer: Somatic and psychosocial consequences
20. Long term quality of life after breast cancer: Comparison of 8-year survivors with population controls